Medline Convenience Kits Recall Due to Lidocaine Quality Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling 48,075 convenience kits containing Huons Lidocaine HCL Injection USP 1% ampules nationwide due to quality issues identified during an FDA inspection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-devices.
What Happened
Medline Industries, LP initiated a voluntary recall of certain convenience kits because they contain Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules subject to a separate recall by Huons Co., Ltd. The action stems from quality issues identified during a recent FDA manufacturing inspection of the drug manufacturing site. The recall is classified as Class II and affects US Nationwide distribution.
Which Products Are Affected
The recall covers 48,075 Medline Convenience Kits with numerous model numbers and lot numbers, including but not limited to: 1) PI CVC KIT 3L 7 FR 16 CM (ECVC8520, Lot 2026031790), 2) NO CATH CENTRAL LINE KIT (CVI4880B, Lot 2026021190), 3) 20G x 6" ARTERIAL CATHETER KIT (ART356, Lot 2026011990), and dozens more such as STCVC03, ARTNC217, ECVC1720, CVI4815, STCVC04, ART350, ECVC6355, UVT980, ECVC5480, P972300A, ECVC825A, ECVC8640, SPEC0291B, ECVC7605, ECVC7330, ECVC7600, ECVC8110, ART660A, ECVC5370B, A3720KIC, DYNJ70152MB, ECVC8180, ECVC8595, DYNDA1954A, SUT10830A, SUT10520, CMPV7203LBB, ECVC8380B, MNS7065A, I500BF85, ART690, ECVC5490, ECVC8633, ECVC6920A, DYNDH1135B, CHT1825, ECVC7485, CVI190, SPEC0051, CMPM7203LBB, ECVC1490A, ECVC3505, DYNDH1406, ECVC8632, ID1135A, ECVC8637, ECVC5080, ECVC1970B, CVI5331, CMPV7203LBPA, ECVC6110B, ART1303, MNS10750A, ECVC7830C, ECVC8616, ECVC8320A, ECVC8385B, ECVC5475, ECVC1700, ART240C, ECVC1950, ECVC8360, SUT4065, ECVC8465 and additional models with corresponding UDI-DI codes and lot numbers detailed in FDA recall Z-2541-2026.
What You Should Do
Consumers and healthcare facilities should stop using the affected kits and contact Medline Industries, LP for return or refund instructions.
Why This Matters
This Class II recall addresses potential quality issues with the included lidocaine ampules that could lead to temporary or reversible adverse health consequences.
Source
FDA Enforcement Report, recall number Z-2541-2026, initiated May 21, 2026. https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,990 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.